Vevorisertib trihydrochloride
Vevorisertib trihydrochloride (ARQ 751 trihydrochloride) is a selective and potent inhibitor of pan-AKT and AKT1-E17K mutations, inhibiting AKT1, AKT2 and AKT3. Vevorisertib trihydrochloride is used in the study of hepatocellular carcinoma and advanced solid tumours.
Product Specifications
CAS Number
1416775-08-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
696.12
Molecular Formula
C35H41Cl3N8O
Notes
Research use only, not for human use.
Receptor
Akt
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog